TIME IN THERAPEUTIC RANGE ≥55% VERSUS <55% ON WARFARIN THERAPY OUTCOMES IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS

被引：1
|
作者：
An, Jaejin [1 ]
Lang, Daniel [1 ]
Fang, Niu [1 ]
Jazdzewski, Kristin [1 ]
Le, Paul [1 ]
Rashid, Nazia [1 ]
Meissner, Brian [1 ]
Mendes, Robert [1 ]
Dills, Diana [1 ]
Ershoff, Dan [1 ]
Borok, Gerald [1 ]
Bruno, Amanda [1 ]
机构：
[1] Kaiser Permanente So Calif, Downey, CA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 63卷 / 12期
关键词：
D O I：
10.1016/S0735-1097(14)60359-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1143-114
引用
收藏
页码：A359 / A359
页数：1
相关论文
共 50 条
  • [21] Uninterrupted dabigatran versus warfarin in the treatment of intracardiac thrombus in patients with non-valvular atrial fibrillation
    Hao, Li
    Zhong, Jing-quan
    Zhang, Wei
    Rong, Bing
    Xie, Fei
    Wang, Jun-tao
    Yue, Xin
    Zheng, Zhao-tong
    Zhu, Qing
    Zhang, Yun
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 190 : 63 - 66
  • [22] Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
    Faye L. Norby
    Lindsay G.S. Bengtson
    Pamela L. Lutsey
    Lin Y. Chen
    Richard F. MacLehose
    Alanna M. Chamberlain
    Ian Rapson
    Alvaro Alonso
    BMC Cardiovascular Disorders, 17
  • [23] Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation
    Nelson, Winnie W.
    Song, Xue
    Coleman, Craig I.
    Thomson, Erin
    Smith, David M.
    Damaraju, C. V.
    Schein, Jeffrey R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (12) : 2461 - 2469
  • [24] Uninterrupted Dabigatran versus Warfarin in the Treatment of Intracardiac Thrombus in Patients with non-Valvular Atrial Fibrillation
    Hao, Li
    Zhong, Jingquan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C229 - C229
  • [25] Effect and risk of novel oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation
    Kawada, Tomoyuki
    JOURNAL OF CARDIOLOGY, 2017, 70 (1-2) : 99 - 99
  • [26] Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
    Norby, Faye L.
    Bengtson, Lindsay G. S.
    Lutsey, Pamela L.
    Chen, Lin Y.
    MacLehose, Richard F.
    Chamberlain, Alanna M.
    Rapson, Ian
    Alonso, Alvaro
    BMC CARDIOVASCULAR DISORDERS, 2017, 17
  • [27] Outcomes After Switching Anticoagulation From Warfarin to DOACs in Patients With Non-valvular Atrial Fibrillation
    Ueda, Shinichiro
    Morimoto, Takeshi
    CIRCULATION, 2019, 140
  • [28] Persistence and outcomes of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation
    Wu, Shanshan
    Xie, Shuo
    Xu, Yingjie
    Que, Dongdong
    Yau, Tung On
    Wang, Lizi
    Huang, Yuanping
    JOURNAL OF CLINICAL NURSING, 2019, 28 (9-10) : 1839 - 1846
  • [29] Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes
    Hernandez, Adrian, V
    Bradley, George
    Khan, Mohammad
    Fratoni, Andrew
    Gasparini, Anna
    Roman, Yuani M.
    Bunz, Thomas J.
    Eriksson, Daniel
    Meinecke, Anna-Katharina
    Coleman, Craig, I
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2020, 6 (04) : 301 - 307
  • [30] Optimal international normalized ratio in warfarin therapy in Korean patients with non-valvular atrial fibrillation
    Bae, M. H.
    Kim, J. H.
    Jang, S. Y.
    Park, S. H.
    Choi, W. S.
    Lee, J. H.
    Yang, D. H.
    Park, H. S.
    Cho, Y.
    Chae, S. C.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1103 - 1103
12345